AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44

Authors: Prinsen, BHCMT De Sain-Van der Velden, MGM Kaysen, GA Straver, HWHC Van Rijn, HJM Stellaard, F Berger, R Rabelink, TJ
Citation: Bhcmt. Prinsen et al., Transferrin synthesis is increased in nephrotic patients insufficiently toreplace urinary losses, J AM S NEPH, 12(5), 2001, pp. 1017-1025

Authors: Ito, Y Goldschmeding, R Bende, RJ Claessen, N Chand, MA Kleij, L Rabelink, TJ Weening, JJ Aten, J
Citation: Y. Ito et al., Kinetics of connective tissue growth factor expression during experimentalproliferative glomerulonephritis, J AM S NEPH, 12(3), 2001, pp. 472-484

Authors: Vos, IHC Rabelink, TJ Dorland, B Loos, R Van Middelaar, B Grone, HJ Joles, JA
Citation: Ihc. Vos et al., L-arginine supplementation improves function and reduces inflammation in renal allografts, J AM S NEPH, 12(2), 2001, pp. 361-367

Authors: Blom, IE van Dijk, AJ Wieten, L Duran, K Ito, Y Kleij, L deNichilo, M Rabelink, TJ Weening, JJ Aten, J Goldschmeding, R
Citation: Ie. Blom et al., In vitro evidence for differential involvement of CTGF, TGF beta, and PDGF-BB in mesangial response to injury, NEPH DIAL T, 16(6), 2001, pp. 1139-1148

Authors: Vanin, AF Huisman, A Stroes, ESG de Ruijter-Heijstek, FC Rabelink, TJ van Faassen, EE
Citation: Af. Vanin et al., Antioxidant capacity of mononitrosyl-iron-dithiocarbamate complexes: Implications for NO trapping, FREE RAD B, 30(8), 2001, pp. 813-824

Authors: Govers, R Rabelink, TJ
Citation: R. Govers et Tj. Rabelink, Cellular regulation of endothelial nitric oxide synthase, AM J P-REN, 280(2), 2001, pp. F193-F206

Authors: Verhaar, MC Rabelink, TJ
Citation: Mc. Verhaar et Tj. Rabelink, The endothelium: a gynecological and obstetric point of view, EUR J OB GY, 94(2), 2001, pp. 180-185

Authors: Schrama, YC van Dam, T Fijnheer, R Hene, RJ de Groot, P Rabelink, TJ
Citation: Yc. Schrama et al., Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation, NETH J MED, 59(1), 2001, pp. 6-15

Authors: Honing, MLH Smits, P Morrison, PJ Burnett, JC Rabelink, TJ
Citation: Mlh. Honing et al., C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels, HYPERTENSIO, 37(4), 2001, pp. 1179-1183

Authors: van Ampting, JMA Hijmering, ML Beutler, JJ van Etten, RE Koomans, HA Rabelink, TJ Stroes, ESG
Citation: Jma. Van Ampting et al., Vascular effects of ACE inhibition independent of the renin-angiotensin system in hypertensive renovascular disease - A randomized, double-blind, crossover trial, HYPERTENSIO, 37(1), 2001, pp. 40-45

Authors: van Zonneveld, AJ Rabelink, TJ
Citation: Aj. Van Zonneveld et Tj. Rabelink, Mesangial cells defy LDL receptor paradigm, KIDNEY INT, 60(5), 2001, pp. 2037-2038

Authors: Vuong, TD de Kimpe, S de Roos, R Rabelink, TJ Koomans, HA Joles, JA
Citation: Td. Vuong et al., Albumin restores lysophosphatidylcholine-induced inhibition of vasodilation in rat aorta, KIDNEY INT, 60(3), 2001, pp. 1088-1096

Authors: Hijmering, ML Stroes, ESG Pasterkamp, G Sierevogel, M Banga, JD Rabelink, TJ
Citation: Ml. Hijmering et al., Variability of flow mediated dilation: consequences for clinical application, ATHEROSCLER, 157(2), 2001, pp. 369-373

Authors: Rabelink, TJ Stroes, E
Citation: Tj. Rabelink et E. Stroes, Atherosclerosis - Defeat of the defense?, CIRCUL RES, 88(5), 2001, pp. 456-457

Authors: Wilmink, HW Twickler, MB Banga, JD Dallinga-Thie, GM Eeltink, H Erkelens, DW Rabelink, TJ Stroes, ES
Citation: Hw. Wilmink et al., Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles, CARDIO RES, 50(3), 2001, pp. 577-582

Authors: Wilmink, HW Stroes, ESG Erkelens, WD Gerritsen, WB Wever, R Banga, JD Rabelink, TJ
Citation: Hw. Wilmink et al., Influence of folic acid on postprandial endothelial dysfunction, ART THROM V, 20(1), 2000, pp. 185-188

Authors: Honing, MLH Hijmering, ML Ballard, DE Yang, YHP Padley, RJ Morrison, PJ Rabelink, TJ
Citation: Mlh. Honing et al., Selective ETA receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans, J AM S NEPH, 11(8), 2000, pp. 1498-1504

Authors: Dijkhorst-Oei, LT Boer, P Rabelink, TJ Koomans, HA
Citation: Lt. Dijkhorst-oei et al., Nitric oxide synthesis inhibition does not impair water immersion-induced renal vasodilation in humans, J AM S NEPH, 11(7), 2000, pp. 1293-1302

Authors: Barton, M Vos, I Shaw, S Boer, P D'uscio, LV Grone, HJ Rabelink, TJ Lattmann, T Moreau, P Luscher, TF
Citation: M. Barton et al., Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: Mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis, J AM S NEPH, 11(5), 2000, pp. 835-846

Authors: Joles, JA Kunter, U Janssen, U Kriz, W Rabelink, TJ Koomans, HA Floege, J
Citation: Ja. Joles et al., Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats, J AM S NEPH, 11(4), 2000, pp. 669-683

Authors: Rabelink, TJ Truin, G de Jaegere, P
Citation: Tj. Rabelink et al., Treatment of coronary artery disease in patients with renal failure, NEPH DIAL T, 15, 2000, pp. 117-121

Authors: Bianchi, G London, GM Marcelli, D Massy, ZA Parfrey, PS Passlick-Deetjen, J Rabelink, TJ Wanner, C
Citation: G. Bianchi et al., Clinical algorithms on cardiovascular risk factors in renal patients, NEPH DIAL T, 15, 2000, pp. 123

Authors: Smits, JHM van der Linden, J Blankestijn, PJ Rabelink, TJ
Citation: Jhm. Smits et al., Coagulation and haemodialysis access thrombosis, NEPH DIAL T, 15(11), 2000, pp. 1755-1760

Authors: Vos, IHC Govers, R Grone, HJ Kleij, L Schurink, M De Weger, RA Goldschmeding, R Rabelink, TJ
Citation: Ihc. Vos et al., NF kappa B decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts, FASEB J, 14(5), 2000, pp. 815-822

Authors: Verhaar, MC Grahn, AY van Weerdt, AWM Honing, MLH Morrison, PJ Yang, YHP Padley, RJ Rabelink, TJ
Citation: Mc. Verhaar et al., Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans, BR J CL PH, 49(6), 2000, pp. 562-573
Risultati: 1-25 | 26-44